Company Overview and News

Philex gold resources shrank in 2017

Philex Mining Corp. has reported double-digit declines in its recoverable gold resource as well as ore reserves last year.
Upvote Downvote

MPCALA taps Leighton for Cavite segment of CALAX

2018-04-09 bworldonline
MPCALA HOLDINGS, Inc. has tapped Leighton Asia to build the Cavite segment of the Cavite-Laguna Expressway (CALAX).
Upvote Downvote

MPIC aims to seal Air21 deal within Q2

2018-04-04 bworldonline
METRO PACIFIC Investments Corp. (MPIC) aims to seal its acquisition of logistics firm Air21 within the second quarter.
Upvote Downvote

Maynilad to spend P1.7B on wastewater projects

2018-04-02 bworldonline
MAYNILAD WATER Services, Inc. has earmarked P1.7 billion for its 2018 wastewater projects, which are aimed at increasing the company’s sewerage coverage while maintaining the reliability of its wastewater network.
Upvote Downvote

MetroPac Water gains a foothold in Vietnam

2018-04-02 bworldonline
METRO PACIFIC Investments Corp. (MPIC) has expanded its footprint in Vietnam with the acquisition of a significant interest in a water company.
Upvote Downvote

MPIC unit to submit proposal for Cavite toll road next month

2018-04-02 bworldonline
CAVITE Infrastructure Corp. (CIC) said it will submit next month to the government a formal proposal for the “Segment 5” project linking the Manila-Cavite Expressway, to which group company MPCALA Holdings, Inc. holds the concession, to Rosario, Cavite.
Upvote Downvote

NAIA consortium willing to shorten concession period

2018-03-21 bworldonline
A CONSORTIUM composed of the country’s biggest conglomerates is willing to reduce its proposed concession period for the rehabilitation of the Ninoy Aquino International Airport (NAIA), but warned this would make the construction of a third runway unlikely.
Upvote Downvote

Payment systems for SMC, MPIC toll roads integrated by April

2018-03-20 bworldonline
INTEROPERABILITY of payment systems in use at expressways operated by San Miguel Corp. (SMC) and Metro Pacific Investments Corp. (MPIC) will be achieved by the end of April, a regulator said.
Upvote Downvote

Maynilad continues to expand pipe network

2018-03-18 bworldonline
MAYNILAD WATER Services, Inc. said it installed 38 kilometers of new water pipes in 2017, resulting in an expansion of its distribution line to 7,675 kilometers.
Upvote Downvote

Panda bond sale ‘in the next week or so’

2018-03-14 bworldonline
THE GOVERNMENT could launch its maiden offer of yuan-denominated — or “panda” — bonds “in the next week or so,” the Finance department announced on Wednesday, even if it maintained that much depends on market conditions.
Upvote Downvote

NLEX Corp. to raise P25 B through fixed rate bonds

2018-03-09 bworldonline
A TOLLWAY unit of Metro Pacific Investments Corp. (MPIC) plans to raise P25 billion through the issuance of fixed rate bonds, with P6 billion slated to be offered for its initial tranche.
Upvote Downvote

NLEx plans P6-billion bond issuance

2018-03-05 bworldonline
NLEX Corp. is planning to issue up to P6 billion in fixed-rate peso-denominated bonds, with the proceeds to be used to refinance debt.
Upvote Downvote

MPIC readies more unsolicited proposals for gov’t

2018-03-01 bworldonline
METRO PACIFIC Investments Corp. (MPIC) is readying more unsolicited infrastructure proposals after sustaining a double-digit growth in core net profit despite continuing regulatory uncertainty.
Upvote Downvote

Philex posts 6% profit growth to P1.66B

Despite a lower output, Philex Mining Corp. posted a 6-percent increase in net income to P1.66 billion last year from P1.57 billion a year ago due to higher metal prices.
Upvote Downvote

Philex Mining Corp. ADR 2017 Q4 - Results - Earnings Call Slides

2018-02-28 seekingalpha
The following slide deck was published by Philex Mining Corp. ADR in conjunction with their 2017 Q4 earnings call.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 718142409